Clover Health Investment shares are trading higher after Citigroup maintained a Neutral rating on the stock and raised its price target from $1 to $1.5.
Portfolio Pulse from Benzinga Newsdesk
Citigroup has maintained a Neutral rating on Clover Health Investment's stock and increased its price target from $1 to $1.5. This has led to a rise in Clover Health's share prices.
August 11, 2023 | 7:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Clover Health's stock is trading higher after Citigroup maintained a Neutral rating and raised its price target from $1 to $1.5.
The increase in Clover Health's share price is directly linked to Citigroup's actions. By maintaining a Neutral rating and raising the price target, Citigroup has shown confidence in Clover Health's performance, which has positively influenced investor sentiment and led to a rise in the stock's price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100